Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 08/10/202
-
Total 13F shares
-
3,225,216
-
Share change
-
+43,663
-
Total reported value
-
$3,724,046
-
Price per share
-
$1.19
-
Number of holders
-
22
-
Value change
-
+$163,809
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) as of Q4 2023
As of 31 Dec 2023,
TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,225,216 shares.
The largest 10 holders included
Magnetar Financial LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Polar Asset Management Partners Inc., Exos TFP Holdings LLC, Vestcor Inc, Point72 Asset Management, L.P., MSD Partners, L.P., WOLVERINE ASSET MANAGEMENT LLC, and Bracebridge Capital, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.